PEX16

Chr 11

peroxisomal biogenesis factor 16

Also known as: PBD8A, PBD8B

The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.82
Clinical SummaryPEX16
🧬
Gene-Disease Validity (ClinGen)
peroxisome biogenesis disorder · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
42 unique Pathogenic / Likely Pathogenic· 214 VUS of 665 total submissions
📖
GeneReview available — PEX16
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.82LOEUF
pLI 0.000
Z-score 2.16
OE 0.49 (0.300.82)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.45Z-score
OE missense 0.91 (0.811.03)
195 obs / 213.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.49 (0.300.82)
00.351.4
Missense OE?0.91 (0.811.03)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 10 / 20.6Missense obs/exp: 195 / 213.6Syn Z: -0.12
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePEX16-related peroxisome biogenesis disorder 8BLOFAR
definitivePEX16-related peroxisome biogenesis disorder 8A (Zellweger)LOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7035th %ile
GOF
0.5269th %ile
LOF
0.3259th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

665 submitted variants in ClinVar

Classification Summary

Pathogenic26
Likely Pathogenic16
VUS214
Likely Benign340
Benign23
Conflicting35
26
Pathogenic
16
Likely Pathogenic
214
VUS
340
Likely Benign
23
Benign
35
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
25
1
0
0
26
Likely Pathogenic
11
5
0
0
16
VUS
2
180
27
5
214
Likely Benign
0
6
170
164
340
Benign
0
1
20
2
23
Conflicting
35
Total38193217171654

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

16 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap PEX16 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PEX16 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →